How effective is Rapaflo for Prostate Examination Abnormal? (a real world drug study)
Summary:
Overall ratings: 2.8/5 Long term ratings: 3.1/5
This is a phase IV clinical study of how effective Rapaflo (silodosin) is for Prostate examination abnormal and for what kind of people. The study is created by eHealthMe from 82 Rapaflo users and is updated continuously.
What is Rapaflo?
Rapaflo has active ingredients of silodosin. It is often used in prostate examination abnormal. eHealthMe is studying from 3,929 Rapaflo users. Check the latest studies of Rapaflo.
What is Prostate examination abnormal?
Prostate examination abnormal is found to be associated with 1,609 drugs and 1,424 conditions by eHealthMe. Check the latest studies of Prostate examination abnormal.
82 people are studied for taking Rapaflo in Prostate examination abnormal
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Rapaflo effectiveness for Prostate examination abnormal (number of people):
Overall:
- not at all: 5
- somewhat: 27
- moderate: 31
- high: 14
- very high: 5
Long Term:
- not at all: 0
- somewhat: 5
- moderate: 14
- high: 6
- very high: 1
Gender of people who take Rapaflo for Prostate examination abnormal *:
- female: 1.22 %
- male: 98.78 %
Age of people who take Rapaflo for Prostate examination abnormal *:
- 0-1: 1.22 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 1.22 %
- 30-39: 1.22 %
- 40-49: 4.88 %
- 50-59: 21.95 %
- 60+: 69.51 %
Who find Rapaflo more effective for Prostate Examination Abnormal?
Gender of people who take Rapaflo for Prostate examination abnormal *:
- female: 0.0 %
- male: 100 %
Age of people who take Rapaflo for Prostate examination abnormal *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 10.53 %
- 50-59: 10.53 %
- 60+: 78.95 %
* Approximation only. Some reports may have incomplete information.
Do you take Rapaflo?
- You can start a phase IV clinical trial to monitor Rapaflo safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Rapaflo (3,929 reports)
Treatments, associated drugs and conditions:
- Prostate examination abnormal (46,217 reports)
How the study uses the data?
The study is based on silodosin (the active ingredients of Rapaflo) and Rapaflo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Apixaban and Lasix - now
- Gastroesophageal Reflux Disease and Facial Paralysis - 4 seconds ago
- Could Onglyza cause Haemorrhage? - 6 seconds ago
- How effective is Prevacid for Gastroesophageal Reflux Disease? - 7 seconds ago
- Could Famotidine cause Renal Impairment? - 9 seconds ago
- Drug interactions of Spiriva and Yupelri - 9 seconds ago
- Drug interactions of Amoxicillin and Colistimethate Sodium - 10 seconds ago
- Drug interactions of Prochlorperazine Maleate and Amicar - 16 seconds ago
- Drug interactions of Sumatriptan Succinate and Voltaren - 16 seconds ago
- Could Nasonex cause Tumor? - 17 seconds ago